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Inverted formin 2 (INF2) encodes a member of the diaphanous
subfamily of formin proteins. Mutations in INF2 cause human
kidney disease characterized by focal and segmental glomerulo-
sclerosis. Disease-causing mutations occur only in the diaphanous
inhibitory domain (DID), suggesting specific roles for this domain in
the pathogenesis of disease. In a yeast two-hybrid screen, we
identified the diaphanous autoregulatory domains (DADs) of the
mammalian diaphanous-related formins (mDias) mDia1, mDia2,
and mDia 3 as INF2_DID-interacting partners. The mDias are Rho
family effectors that regulate actin dynamics.We confirmed in vitro
INF2_DID/mDia_DAD binding by biochemical assays, confirmed the
in vivo interaction of these protein domains by coimmunoprecipi-
tation, and observed colocalization of INF2 and mDias in glomer-
ular podocytes. We investigated the influence of this INF2_DID/
mDia_DAD interaction on mDia mediated actin polymerization and
on serum response factor (SRF) activation. We find that the
interaction of INF2_DID with mDia_DAD inhibited mDia-mediated,
Rho-activated actin polymerization, as well as SRF-responsive gene
transcriptional changes. Similar assays using the disease-causing
E184K and R218Q mutations in INF2_DID showed a decreased
effect on SRF activation and gene transcription. The binding of
INF2_DID to mDia_DAD may serve as a negative regulatory
mechanism for mDias’ function in actin-dependent cell processes.
The effects of disease-causing INF2mutations suggest an important
role for this protein and its interaction with other formins in mod-
ulating glomerular podocyte phenotype and function.
Formins are a group of heterogeneous actin nucleating proteinsthat regulate a variety of cytoskeleton-dependent cellular
processes (1–5). Inverted formin 2 (INF2) is a unique member of
the formin family. Although it has a domain structure similar to
the diaphanous formins [a diaphanous-inhibitory domain (DID),
formin homology 1 and 2 domains (FH1 and FH2), and a di-
aphanous autoregulatory domain (DAD)], it is capable of not
only accelerating actin polymerization, but also accelerating actin
depolymerization (6). INF2’s depolymerizing activity relies on the
combination of its FH2 domain and C terminus, including a DAD
that also serves as an actin monomer-binding WH2 domain
(Wasp homology domain 2). INF2’s depolymerization activity is
regulated via an autoinhibitory interaction of its DID and DAD
(6). A similar intramolecular interaction between the DID and
DAD also regulates the diaphanous-related formin mDia1, al-
though, in this case, the result is to inhibit its actin polymerizing
function (7). In the case of the mammalian diaphanous-related
formins (mDias), the autoinhibition of the DID/DAD interaction
can be relieved by the competitive binding of the small GTPase
RhoA to the DID (8). Recently, GTP-bound Cdc42 has recently
been shown to bind to the DID of INF2 and modulate INF2’s
function in transcytosis (9).
We recently demonstrated that mutations in INF2 cause a form
of autosomal-dominant focal and segmental glomerulosclerosis
(FSGS) (10). INF2 is highly expressed in glomerular podocytes,
terminally differentiated cells whose characteristics are highly
cytoskeleton-dependent. These characteristics include a branched
structure that terminates in filopodia-like foot processes, and
the maintenance of a specialized cell–cell junction known as the
glomerular slit diaphragm (11–13). The importance of the actin
cytoskeleton in maintaining the glomerular filtration barrier is
supported by the fact that mutations in α-actinin-4, an actin cross-
linking protein, cause a similar formof autosomal-dominant FSGS
(14). Numerous lines of evidence support the notion that podo-
cytes are highly sensitive to perturbations in their actin cytoskel-
eton (15). Consistent with this, FSGS-associated mutant forms of
INF2 induce distinct patterns of actin polymerization in cultured
podocytes compared with WT INF2 (10). The mechanism un-
derlying these differences remains unknown.
To date, all FSGS-associated mutations in INF2 alter highly
conserved residues within the DID and result in genetically
dominant disease (10). We conjectured that these mutations may
result in the disruption of an interaction of the DID with a regu-
latory protein, and/or perturb the role of the DID of INF2 to
regulate its function through its binding to the DAD. Here we
report that the mDia family are INF2-interacting proteins. We
show that FSGS-associated mutations in INF2 impair its ability to
bindmDia_DAD. Furthermore, we find that the interaction of the
INF2_DID with the mDia_DAD acts to limit mDia-mediated
actin polymerization and serum response factor (SRF)-dependent
transcription in a Rho- and CDC42-dependent manner.
Results
Diaphanous Formins Bind the INF2_DID in Yeast Two-Hybrid Assay.
Weused a yeast two-hybrid assay to screen a human kidney cDNA
library with the DID of INF2 to identify interacting proteins.
Captured candidate INF2_DID binding partners included eight
independent clones encoding mDia family members (Table 1):
diaphanous homologue 1 (DIAPH1, mDia1), diaphanous ho-
mologue 2 (DIAPH2, mDia3) and diaphanous homologue 3
(DIAPH3, mDia2). All the captured mDia clones were DAD-
containing sequences ranging from DAD alone to those con-
taining formin homology (FH) domains, i.e., FH1-FH2-DAD.
For simplicity, we refer to any single member of this family as
mDia and the whole group as the mDias.
INF2_DID Interacts with mDia_DAD. Among the 20 sequence frag-
ments from mDia1, mDia2, or mDia3 captured by using
INF2_DID as bait, all clones contained at least the full DAD se-
quence, with the shortest (clone 1, aa 1,181–1,262; Table 1) lacking
any other defined domains.Weconjectured thatmDia_DADmight
serve as a site for binding to INF2_DID. To confirm that this in-
termolecular DID/DAD binding is the basis for an association
between INF2 and the mDias, we compared the binding of INF2_
DID to mDia_DAD (including mDia1_DAD, mDia2_DAD, and
mDia3_DAD) and FH1-FH2-C terminus constructs of the mDias
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lacking the DAD (including mDia1_FH1-FH2-CΔDAD, mDia2_
FH1-FH2-CΔDAD, and mDia3_FH1-FH2-CΔDAD) in a yeast
mating system. As shown in Fig. 1A, the mDia_DAD regions alone
were sufficient for binding to INF2_DID, whereas with the deletion
of DAD from the longest captured FH1-FH2-C fragments, the
interactions were abolished (Fig. 1).
Given the previously demonstrated INF2_DID/DAD intra-
molecular interaction (6), we were surprised that we did not find
any INF2_DAD sequences among the interactors identified in our
screen. To explore this further, we compared the DAD sequences
of the diaphanous formins with INF2_DAD by using ClustalW
software. As shown in Fig. 1B, mDia1, mDia2, and mDia3 share
highly similar DAD sequences. By contrast, the INF2_DAD shows
considerably less homology, suggesting that our inability to detect
INF2_DAD in our screen might reflect a difference between the
strength of the interactions between INF2_DID and mDia_DAD
compared with INF2_DAD. To exclude the possibility that the low
abundance of INF2 in the kidney cDNA library usedmight have led
to its absence from our list of captured proteins, we expressed
INF2_DAD (aa 965–1,237) in yeast, and specifically examined its
interaction with INF2 DID in a yeast mating system (Fig. 1A). A
specific interaction between INF2 DID and DAD was still un-
detectable in this system.
We next used a fluorescence polarization assay to measure in
vitro DID/DAD binding directly. As shown in Fig. 1C and Table 2,
mDia1_DID bound mDia2_DAD [a representative mDia_DAD
(16)] with a Kd of approximately 2 μM, whereas INF2_DID bound
INF2_DADweakly, with aKd of approximately 16 μM. INF2_DID
has a similar weak affinity for mDia2_DAD (Kd, 15.8 μM).
INF2_DID displays some specificity for mDia2_DAD, as it binds
much more weakly to the DAD region of another diaphanous
formin, FRL2 (Formin-like 3, FMNL3).We used point mutants in
mDia_DAD to help understand the difference between the vari-
ous DID/DAD interactions. The M1041 and L1044 residues in
mDia_DAD have been shown to be critical in mediating the
homodimeric DID/DAD interaction of the mDias (16). Although
mutating these residues strongly inhibits (L1044A) or abolishes
(M1041A) the interaction of mDia2_DAD with mDia1_DID, it
had a less pronounced effect on the interaction with INF2_DID,
suggesting that the INF2_DID/mDia_DAD interaction may use
additional contact sites.
Cellular Interaction of INF2 and mDias Is Regulated by Rho Activity.
We performed coimmunoprecipitation (co-IP) experiments to
determine whether INF2_DID/mDia_DAD binding reflected an
in vivo interaction of mDias and INF2. In 293T cells in which
FLAG-INF2 and either mDia1-Myc or mDia3-Myc were expres-
sed, Myc-tagged mDias could be precipitated by anti-FLAG
antibody (Fig. 2A). In 293T cells in which FLAG-INF2 and GFP-
mDia2 were expressed, GFP-mDia2 was also precipitated by anti-
FLAG antibody (Fig. 2B). To address the specificity of the in-
termolecular INF2/mDia interaction, we compared the binding of
the INF2_DID with FH1-FH2-DAD constructs from mDia1,
mDia2, INF2, and three other formins: FRL1 (Formin-like 1,
FMNL1), FRL2 (FMNL3), and FHOD1. As shown in Fig. 2C, we
demonstrated interactions of INF2 with the DAD-containing
sequence from INF2, mDia1, and mDia2, but not with the DAD
from the other three formins tested. We also demonstrated an
interaction of endogenous INF2 and mDia in untransfected cells.
As shown in Fig. 2D, the endogenous INF2 was precipitated by
using an antibody against mDia1/2.
In parallel, we examined the response of endogenous binding of
INF2 and mDia to manipulations of intracellular Rho activity. As
shown in Fig. 2D, the INF2/mDia interaction was enhanced by
lysophosphatidic acid (LPA), a potent Rho activator, but abol-
ished by C3 transferase, a selective Rho inhibitor. To determine
whether F-actin mediated an indirect association of INF2 and
the mDias, we performed co-IP in the presence of latrunculin A
(LatA), which disrupts actin polymerization. The effects of the
pharmacological manipulation of Rho on the INF2/mDia in-
teraction were similar in the presence or absence of LatA. By
reprobing the blots, we found very little actin precipitating with
the anti-mDia antibody (Fig. 2D). In a complementary experiment
(Fig. 2 E and F), the INF2/mDia binding increased in response
to RhoA or CDC42 activation induced by the overexpression of
constitutively active RhoA (Q63L) or CDC42 (Q61L). By contrast,
the interaction was decreased with the inhibition of RhoA or
Table 1. INF2_DAD captured mDiafamily members by using
a yeast two-hybrid system
Clone
Hits
(N = 20) Protein Fragment, aa
Domains
included
1* 3 mDia1 1,181–1,262
(C terminus)
DAD
2 1 — 1,146–1,262 DAD
3 9 — 1,088–1,262 FH2-DAD
4 1 — 1,026–1,262 FH2-DAD
5 2 — 1,024–1,262 FH2-DAD
6* 1 — 596–1,262 FH1-FH2-DAD
7 2 mDia2 749–1,149
(C terminus)
FH1-FH2-DAD
8 1 mDia3 637–1,103
(C terminus)
FH2-DAD
*Shortest and the longest fragments captured for each gene transcript.
Fig. 1. INF2 interacts with mDias. (A) The interactions between INF2_DID
and mDia_DAD were detected in a yeast mating system. INF2_DID in the
pGBKT7 vector was transformed into the AH109 yeast strain, with the empty
vector as a negative control. Formin fragments mDia1_DAD, mDia2_DAD,
mDia3_DAD, mDia1 FH1-FH2-CΔDAD, mDia2 FH1-FH2-CΔDAD, and mDia3
FH1-FH2-CΔDAD were cloned into pACT2 and transformed into the Y187
yeast strain. The transformants were mated and dotted on QDO agar plates.
The interactions between INF2_DID and mDia truncations are displayed in
the bottom row. (B) Sequence alignment of DAD in mDias and INF2. (C)
DID/DAD binding measured by fluorescence polarization binding experi-
ments by using fluorescein-labeled mDia2_DAD [WT and mutants, M1041A
and L1044A], INF2-DAD or FRL2-DAD, and DID-containing N-terminal (NT)
constructs of mDia1 or INF2.
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CDC42 by the expression of dominant-negative RhoA (T19N) or
CDC42 (T17N).
Immunofluorescence staining demonstrated colocalization of
the expressed INF2 and mDia in cultured podocytes as well as in
NIH 3T3 cells (Fig. 3A). Staining for both proteins in mouse
kidney showed colocalization of INF2 and mDias within podo-
cytes as well as in vessel endothelium (Fig. 3C). We also detected
the prominent expression of mDia along the brush border of
proximal tubular cells where the expression of INF2 was absent.
We noted that in cells cotransfected with mDia2ΔGBD (GFP-
FH1-FH2-C_mDia2) and INF2, INF2 showed better colocaliza-
tion in a fiber-like pattern compared with the full mDia2 (Fig. 3B).
INF2/mDia DID/DAD Interaction Interferes with the Rho/F-Actin/SRF
Pathway Mediated by mDias. The mDias are Rho effectors that
mediate Rho activated actin polymerization and the subsequent
SRF signaling (1, 17). To investigate if mDia activation of F-actin
formation and SRF activation are influenced by the occupation of
mDia_DAD by INF2_DID, we tested the influence of INF2_DID
on the polymerization activity of mDia1_FH1-FH2-DAD in a
pyrene-actin fluorescence-based assay. As shown in Fig. 4B,
INF2_DID inhibited the actin nucleating activity of mDia1 FH1-
FH2-DAD in a dose-dependent manner. Its effect is weaker than
that of the mDia1_DID construct, likely a reflection of the lower
affinity of the INF2_DID/mDia_DAD interaction compared with
the mDia_DID/mDia_DAD interaction. We used a luciferase
reporter system to assay the effect of INF2_DID onmDia-induced
SRF activity in 293T cells. Overexpression of mDia2 resulted in a
decrease in theG-actin/F-actin ratio (Fig. 4A), reflecting increased
incorporation of actinmonomers into F-actin. As shown in Fig. 4C,
mDia induced SRF activation was attenuated by the pretreatment
of Rho-inhibiting exoenzyme C3 transferase or the actin depoly-
merizer LatA, and the coexpression with INF2_DID produced
a comparable attenuation of mDia2-induced SRF activation.
These inhibitory effects coincided with an increased G-actin/
F-actin ratio, compared with the cells in which mDia2 is overex-
pressed alone (Fig. 4A). The inhibition of INF2_DID on mDia2-
induced SRF activation was altered by disease-causing point
mutations. As shown in Fig. 4D, mDia2-induced SRF activation
was inhibited by WT INF2_DID and the mutants E184K, S186P,
and R218Q. The inhibition of SRF activation in the presence of
E184KorR218Qmutants wasweaker than the inhibition observed
with WT INF2_DID. These differences roughly corresponded to
the strength of the interaction of INF2_DID mutants to mDia.
To investigate the antagonism of INF2_DID on mDia-induced
SRF activation and the downstream influence on the biological
phenotype of disease-relevant kidney cells, we evaluated the ex-
pression of several known SRF regulated genes by RT-PCR. By
searching the Gene Expression Omnibus database, we selected 11
genes from dataset GDS1486 with transcript levels reported to be
up-regulated or down-regulated in SRF-null neonatal cardiomyo-
Fig. 2. (A and B) In vivo interaction of INF2 and mDias detected by co-IP. In 293T cells coexpressing FLAG-INF2 and mDias (mDia1-Myc or mDia3-Myc in A, GFP-
mDia2 in B), mDias were immunoprecipitated (IP) by using anti-FLAG. (C) In 293T cells coexpressing INF2-FLAG and GFP-FH1-FH2-C constructs of formins, the
intermolecular interaction was detected of INF2 with mDia1, mDia2, or INF2 itself, but not with FRL1, FRL2, or FHOD1. (D–F) The endogenous interaction of
INF2 and mDias in response to intracellular Rho/CDC42 activity. 293T cells pretreated with LPA (25 μM) or cell permeable C3 transferase (2 μg/ml) (D), or
transfected with plasmids encoding different forms of RhoA (wt, Q63L, or T19N in E) or CDC42 (wt, Q61L, or T17N in F) . The cell lysates (LYS) were
immunoprecipitated with anti-mDia1/2 and then immunoblotted with anti-INF2. To exclude the interference of actin in the binding assay, co-IP was per-
formed in the presence/absence of 10 μM of Latrunculin A, and the blots were reprobed with anti-actin (D). Rho or CDC42 activity was measured using
Rhotekin RBD or PAK1PBD pull down (D–F).
Table 2. Kd values for mDia1 N terminus and INF2 N terminus
for DAD peptides
Peptide INF2 N terminus, μM mDia1 N terminus, μM
mDia2_DAD WT 15.8 2.1
mDia2_DAD M1041A 38.0 (2.4-fold vs. WT) Unmeasurable*
mDia2_DAD L1044A 69.0 (4.4-fold vs. WT) 84.2 (40-fold vs. WT)
INF2_DAD 16.2 —
FRL2_DAD Unmeasurable* —
*No measurable anisotropy increase at 50 mM of the N-terminal construct.











cytes (18). ACTN4, CTGF, CYR61, MYH9, MYL9, and TPM1
are previously reported SRF-regulated genes (19). The other five
genes assayed—ANGPTL1, FAS, HIF1A, SMAD7, and Trap1,
which showed increased expression in SRF-null cardiomyocytes—
served here as SRF down-regulated genes. As shown in Fig. S1,
consistent with the increased SRF activity measured by luciferase
reporter gene assay, the transcripts of the SRF up-regulated genes
(MYH9, MYL9, ACTN4, CYR61, and TPM1) were increased to
various degrees by mDia2, and this increase was reversed by the
coexpression of INF2_DID. Similarly, the mDia2-induced down-
regulation of ANGPTL1, HIF1A, SMAD7, and TRAP1 was also
diminished by INF2_DID. Thus, INF2_DID, presumably through
the INF2_DID/mDia2_DAD interaction, antagonizes the effect of
mDia2 on SRF-regulated genes. In addition, we found that the
effects of INF2_DID on the expression of SRF-regulated genes
were diminished by the disease-causing mutations, particularly
E184K and R218Q, consistent with the variation in SRF activity
seen in the luciferase assays (Fig. 4D).
INF2 Mutants Interfere with Interaction Between INF2 and mDias.We
investigated whether the presence of these mutations in INF2
would alter its ability to interact to the mDias. We compared the
heterogeneous interaction of INF2_DID mutants and mDia_
DAD containing fragments in a yeast mating system. As shown
in Fig. 5B, the S186P mutation did not abolish the interaction,
whereas INF2_DID carrying the E184K or R218Q mutation
was unable to bind to mDia fragments. To further confirm the
possible structure/function relationship of these disease-causing
mutations, we subcloned the full-length INF2, including WT,
E184K, S186P, and R218Q mutants, into a FLAG tagging
vector. As shown in Fig. 5C, in 293T cells cotransfected with
FLAG-INF2 constructs and GFP-mDia2, mDia2 coprecipitated
with WT and S186P mutant INF2, but not with E184K or
R218Q mutant INF2. Overexpressed mDia2 showed better
colocalization with WT and S186P mutant INF2 compared with
Fig. 3. Colocalization of INF2 and mDias in vivo and in vitro. (A) NIH/3T3
cells and podocytes were cotransfected with plasmids encoding FLAG-INF2
and GFP-mDia2. These proteins were detected by using anti-FLAG and anti-
GFP antibodies (red, FLAG; green, GFP; yellow, merged). The merged signal
was distributed in filopodia-like structures in podocytes (A, arrows). (B) NIH/
3T3 cells and podocytes were cotransfected with plasmids encoding FLAG-
INF2 and GFP-FH1-FH2-C_mDia2 (GFP-mDia2ΔGBD). The merged signal lo-
calized to filament-like structures (B, arrows). (C) In vivo colocalization of
endogenous INF2 and mDia1 in mouse kidney. A frozen section (4 μm) was
double-stained with rabbit anti-INF2 and chicken anti-mDia1. The merged
signal was distributed in podocytes and in vessel endothelium (arrows).
Fig. 4. INF2_DID interferes in
themDia2-mediatedRho/F-actin/
SRF pathway. G-actin/F-actin dis-
tribution (A), actin polymeriza-
tion assay (B), and SRF acti-
vation (C and D) were measured
in 293T cells with overexpression
of mDia2, with and without
coexpression of INF2_DID, with
cells transfected with the empty
plasmid serving as a control. (A)
The ratio of G-actin and F-actin
representing alterations in actin
transfer from G to F pool during
the change of experimental con-
ditions. Overexpression ofmDia2
induced F-actin accumulation,
which was reversed by INF2_DID
coexpression, LatA (10 μm), or C3
transferase (2 μg/mL). (B) Pyrene-
actin polymerization assays with
4 μM 5% pyrene-labeled actin
monomers and2.5 nMofmDia1_
FH1-FH2-DAD in the absence or
presence of mDia1_DID or INF2_
DID (0–4 μM). mDia1_DID and
INF2_DID inhibited mDia1_FH1-
FH2-DAD–mediated actin poly-
merization. The inhibitory effect
of INF2_DIDwasweaker than that ofmDia1_DID. (C andD) SRF activitywasmeasured by dual luciferase reporter gene assay and the result was expressed as relative
activity normalized as fold of control. Data are expressed asmean± SD from three independent experiments.Means of relative luciferase activitywere compared in
eachgroupbyone-wayANOVA.Dunnett testwas performed for group INF2_DID, C3 transferase, or LatA examined in comparisonwith the control ormDia2 group.
Background SRF activitywas inhibited by LatAor C3 transferase (*P< 0.05 vs. control), but not by INF2_DID.mDia2-induced SRF activationwas inhibitedby INF2_DID
coexpression, C3 transferase, or LatA (*P < 0.05 vs. mDia2 only). (D) SRF activation was compared in 293T cells with the coexpression ofmDia2 and INF2_DID (WT or
E184K, S186P,R218Qmutants). The cell lysateswereprecipitatedwithanti-mDia1/2. The interactionofmDia2and INF2waseliminatedbyE184KorR218Qmutations.
mDia2-induced SRF activation was antagonized by INF2_DID WT, E184K, S186, and R218Q mutants. ΔSRF (SRFmDia2+INF2_DID-SRFmDia2) was compared by one-way
ANOVA. Dunnett test was performed to compare the inhibitory effects of the mutants versus that of WT. mDia2-induced SRF by E184K or R218Q was significantly
weaker than that byWT (*P < 0.05 vs. WT).
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E184K and R218Q INF2 (Fig. 5D; Fig. S2 shows additional
cell images).
Discussion
By using a yeast two-hybrid screen for INF2_DID interacting pro-
teins, we captured sequences containing the DAD region of sev-
eral diaphanous-related formins. The shortest common interacting
fragment mapped to the DAD region. This suggested that the
mDia DAD region is a site for recognition, binding, and regu-
lation by INF2_DID. We made truncations of mDia_DAD and
mDiaΔDAD and compared their ability to interact with INF2_
DID in a yeast mating system. mDia_DAD alone was sufficient for
interaction with INF2_DID. With the deletion of DAD, the inter-
actions between INF2_DID and the DAD-containing sequences
of mDia were disrupted, indicating that mDia_DAD is required for
the mDia/INF2 interaction. We did not observe INF2 DID/DAD
binding in our yeast two-hybrid system, despite the fact that INF2_
DIDshows similar binding affinity for INF2_DADandmDia_DAD
in vitro. Although we do not have a definite explanation for this
difference, various aspects of cellular context (e.g., the binding of
actin to the INF2_DAD/WH2) are likely responsible. Interestingly,
mutations that disrupt the mDia_DID/mDia_DAD interaction
showed less pronounced effects on the INF2_DID/mDia_DAD
interaction, suggesting that the binding sites may be different, with
differing biological roles and regulatory mechanisms.
The ability of INF2 to interact with other formins appears
specific to the mDia subfamily, as DAD-containing constructs of
other formins FRL1, FRL2, and FHOD1 did not interact with
INF2 in co-IP experiments. Copeland et al. demonstrated het-
erodimerization between close members of mDias based on
DID/DAD interactions and demonstrated that this interaction
enabled them to function as negative regulators of each other
(20). Our investigation suggests a similar intermolecular in-
teraction between more distantly related subgroups of formins.
Studies using kidney disease-causing INF2_DID mutations sug-
gest that disruption of this interaction is a possible contributor to
this form of human disease.
We demonstrated an in vivo interaction between the full-length
proteins, with colocalization of INF2 and mDias in podocytes.
Our in vitro fluorescence polarization assays suggest that the in-
teraction of mDia_DAD with mDia_DID is greater than the in-
teraction of INF2_DID with mDia_DAD. This is consistent with
the speculation that the INF2/mDia transinteraction is not the
predominant state in vivo, and that themDia intramolecular DID/
DAD interaction is favored.
Immunofluorescence staining showed greater colocalization of
INF2 with a GTPase binding domain (GBD) absent form of
mDia2 (mDia2ΔGBD), suggesting that the presence of this GBD
might interfere with the accessibility of mDia2 for INF2_DID. In
the model depicted in Fig. S3, the binding of active Rho (RhoA-
GTP) to the N-terminal GBD of mDia family members inhibits
the DID/DAD interaction, leading to disautoinhibition (7, 16).
INF2 may have more access to the mDias in the disinhibited
conformation, favoring the INF2_DID/mDia_DAD interaction.
To test this, we perturbed intracellular Rho activity by using
chemical compounds and overexpression of plasmids encoding
Rho (constitutively active or dominant-negative) and found that
the INF2/mDia association is regulated by Rho activation. We
also found that the interaction of INF2 and mDias was regulated
by CDC42 activation.
The interaction of INF2 with mDias may allow these molecules
to function as regulators of each other. As mDias are effectors of
Rho in regulating cytoskeleton dynamics, we investigated the
INF2/mDia interaction on actin polymerization and on SRF-
regulated gene transcription. mDias are essential effectors me-
diating Rho-induced activation of the megakaryoblastic leukemia
1/SRF pathway (Fig. S3). In this model, the autoinhibited state of
mDia is relieved by binding to active RhoA, and then mediates
actin polymerization with the exposure of the functional FH2
domain. mDia activation promotes G-actin incorporating into
Fig. 5. Effect of disease-causing INF2 mutations on mDia interaction. (A) The expression of WT and mutants of INF2_DID in AH109 was detected by im-
munoblotting with an antibody against Myc-Tag. The plasmids (pACT2) carrying candidate proteins were transformed Y187 yeast strain. (B) The trans-
formants were mated and dotted on QDO agar plates. The interactions between INF2_DID (WT) and the candidate protein fragments of mDia1, mDia2, and
mDia3 were tested (column labeled WT), as were the interactions of INF_DID mutants (E184K, S186P, and R218Q) with the captured fragments. (C) 293T cells
were cotransfected with plasmids encoding GFP-mDia2 and FLAG-INF2 mutants. The cell lysates were subjected to immunoprecipitation with anti-FLAG
antibody. Immunoprecipitation of INF2 with the E184K and R218Q mutants did not bring down mDia2, in contrast to WT and S186P mutants. (D) Podocytes
were cotransfected with plasmids encoding GFP-mDia2 and FLAG-INF2 mutants and subjected to double staining of FLAG and GFP-tagged proteins (red,
FLAG; green, GFP; yellow, merged).











F-actin, releasing megakaryoblastic leukemia 1, which then binds
SRF and activates gene transcription.
In our model, the occupation of mDia functional sites by the
heterogeneous INF2_DID/mDia_DAD interaction interferes
with actin polymerization and consequent SRF activation. Thus,
this INF2_DID/mDia_DAD interaction serves as a potential
negative-regulatory mechanism for Rho activation of mDia. This
negative regulation affects SRF activation. Several of these SRF-
regulated genes have known roles in the development of FSGS
and/or podocyte biology (21, 22). Here we found that the en-
hanced SRF activity and SRF-targeted gene transcription induced
by mDia were largely reversed by the coexpression of INF2_DID,
confirming that the heterogeneous DID/DAD interaction con-
tributes to the negative modulation of Rho/mDia/SRF pathway
activation and the consequent phenotype of target cells.
Two disease-causing mutations in INF2_DID, E184K and
R218Q (10), disrupted the interaction with mDia_DAD binding
as detected by yeast mating and co-IP. We also found that the
inhibitory effects of INF2_DID on mDia-induced SRF activity
and SRF-regulated gene transcription were disrupted by these
mutations. E184 and R218 thus appear to be critical for the in-
teraction between the two domains, and the pathogenic signifi-
cance of these mutants may lie in their impaired ability to
interact with and regulate mDia-mediated pathways.
In conclusion, we have shown that binding of INF2_DID to
mDia_DAD binding mediates an association between INF2 and
mDias. The in vivo interaction of these proteins depends on Rho
GTPase signaling. In podocytes, Rho signaling may be triggered
by various extracellular stimuli. When the autoinhibitory effect
of of mDia_DID on mDia_DAD is relieved by active Rho, INF2
is able to interact with mDia_DAD. This regulatory activity
inhibits Rho/mDia-mediated actin polymerization, and thus
modulates the cell’s responses downstream of Rho pathway ac-
tivation. Disease-causing mutations in INF2_DID can disrupt
this INF2_DID/mDia_DAD interaction, alter the regulation of
the mDias, and lead to a disturbance in actin dynamics. This
leads also to altered SRF activity and SRF responsive gene
transcription and, perhaps, dysregulated podocyte behavior. The
full physiological and the pathophysiological significance of the
INF2/mDia interaction in vivo is not yet clear. This interaction
between INF2 and mDias may provide a mechanism for the
subtle regulation of formin activity in cytoskeletal regulation. In
the glomerular podocyte, where INF2 mutations lead to an overt
human phenotype, this INF2-mediated cytoskeletal regulation
may be particularly important.
Materials and Methods
Please refer to the SI Methods for detailed materials and methods.
Plasmids. Plasmid constructs were generated as described in SI Methods.
Protein Preparation and Fluorescence Polarization. N-terminalmDia1 [mouse, aa
1 -548(DID)], FH1-FH2-DAD, and IND2_DID were expressed in bacteria and purified
(5, 7). The mDia2-DAD peptide (acetyl-CDETGVMDSLLEALQSGAAFRRKRG-
amide) was synthesized and labeled with fluorescein-maleimide as described
previously (7). Proteins were dialyzed into binding buffer (10 mM imidazole-
HCl, pH 7.0, 50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 0.2 mM ATP, 0.5 mM DTT,
and 0.02% polyethylene glycoldodecyl ether) before measurements. DID/
DAD binding was measured by fluorescence polarization using fluorescein-
labeled mDia2_DAD [WT and mutants, M1041A and L1044A], INF2-DAD or
FRL2-DAD, and DID-containing N-terminal (NT) constructs of mDia1 or INF2.
Actin Polymerization by Fluorescence Spectroscopy. Pyrene-actin fluorescence
assay was performed as described previously (7).
Dual-Luciferase Reporter Gene Assays. SRF activity was detected by a dual-
luciferase reporter gene assay (Promega) as detailed in SI Methods.
Cellular G-Actin/F-Actin Assay. Changes in the G-actin/F-actin ratio in response
to expression of proteins were studied by using a G-actin/F-actin in vivo assay
kit (Cytoskeleton).
Rho/CDC42 Activation. The Rho/CDC42 activation was detected by pull-down
assay by using Rho and CDC42activation kits (Upstate Biotechnology) as de-
tailed in SI Methods.
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